Bank of America’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,080
Closed -$181K 7374
2016
Q1
$181K Buy
+2,080
New +$182K ﹤0.01% 5181

Other funds holding TNDM

Bank of America's TNDM Position: Q1 2026 in Review

Bank of America reduced its Tandem Diabetes Care (TNDM) stake by 47% in Q1 2026, selling an estimated $7.15M and leaving 373,224 shares worth $7.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

Bank of America first reported a position in TNDM in Q4 2013 and has held it in 50 quarters since. The position peaked at $25.5M in Q2 2024. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Bank of America held 373,224 shares of Tandem Diabetes Care worth $7.15M as of Q1 2026.
  • Bank of America sold 329,279 Tandem Diabetes Care shares in Q1 2026, an estimated $7.15M.
  • Tandem Diabetes Care made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3200 holding.
  • Bank of America first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 50 quarters since.
  • Bank of America's Tandem Diabetes Care position peaked at $25.5M in Q2 2024.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.